A clinical case of ischemic stroke in a young patient with thrombophilia

Julia D. Minina , Inna A. Strelnikova , Anastasia A. Svetkina , Vladimir A. Kalinin

Neurology Bulletin ›› 2020, Vol. LII ›› Issue (2) : 102 -104.

PDF
Neurology Bulletin ›› 2020, Vol. LII ›› Issue (2) : 102 -104. DOI: 10.17816/nb16456
Clinical case reports
research-article

A clinical case of ischemic stroke in a young patient with thrombophilia

Author information +
History +
PDF

Abstract

A clinical observation is presented of a young patient with a rare form of homozygous mutation, which caused recurrent pulmonary embolism, ischemic stroke in the left middle cerebral artery basin. To determine the etiology of recurrent thrombosis, instrumental diagnostic methods were performed to exclude dissection of extra- and intracranial arteries, heart diseases, as well as laboratory methods to detect thrombophilia, antiphospholipid syndrome, connective tissue diseases, and the blood system. According to the results of the examination, the patient revealed a homozygous mutation of the plasminogen activator inhibitor PAI-1, which, in the absence of other factors, can be considered as a probable cause of recurrent thrombosis. During treatment, the patient’s condition improved, focal neurological symptoms partially regressed. As a secondary prophylaxis, the patient was prescribed lifelong administration of warfarin under the control of INR.

Keywords

stroke / thromboembolism / homozygous mutation / anticoagulant therapy

Cite this article

Download citation ▾
Julia D. Minina, Inna A. Strelnikova, Anastasia A. Svetkina, Vladimir A. Kalinin. A clinical case of ischemic stroke in a young patient with thrombophilia. Neurology Bulletin, 2020, LII(2): 102-104 DOI:10.17816/nb16456

登录浏览全文

4963

注册一个新账户 忘记密码

References

[1]

Пизова Н.В. Тромбофлии: генетические полиморфизмы и сосудистые катастрофы. М.: ИМА-ПРЕСС. 2013; 248 с. [Pizova N.V. Thrombophilia: genetic polymorphisms and vascular catastrophes. M.: IMA-PRESS. 2013; 248 p.]

[2]

Franchini M., Veneri D., Salvagno G. et al. Inherited thrombophilia. Crit. Rev. Clin. Lab. Sci. 2006; 43 (3): 249–290. DOI: 0.1080/10408360600552678.

[3]

Manucci P.M. The molecular basis of inherited thrombophilia. Vox. Sang. 2000; 78: 39–45.

[4]

Cazenave J., Gachet C. ADP-receptor activation and platelet aggregation. Pharmacol. Res. 1995; 31: 291–291. DOI: 10.1016/1043-6618(95)87424-0.

[5]

Folsom A. Hemostatic risk factors for atherothrombotic disease: An epidemiologic view. Thrombosis and Haemostasis. 2001; 86 (07): 366–373. DOI: 10.1055/s-0037-1616234.

[6]

Руксин В.В. Тромбозы в кардиологической практике. СПб.: Невский Диалект. М.: Бином. 1998; 126 с. [Ruxin V.V. Thrombosis in cardiology practice. St. Petersburg: Nevsky Dialect. M.: Binom. 1998; 126 p.]

[7]

Шиффман Ф.Дж. Патофизиология крови. Пер. с англ. Под ред. Ю.В. Наточина. М.: Бином. 2001; 446 с. [Schiffman F.J. Pathophysiology of blood. Per. from English ed. Yu.V. Sharpening. M.: Binom. 2001; 446 p.]

[8]

Баркаган З.С. Учение о тромбофилиях на современном этапе. Consil. med. 2000; 6: 61–65. [Barkagan Z.S. The doctrine of thrombophilia at the present stage. Consil. med. 2000; 6: 61–65.]

RIGHTS & PERMISSIONS

Minina J.D., Strelnikova I.A., Svetkina A.A., Kalinin V.A.

AI Summary AI Mindmap
PDF

137

Accesses

0

Citation

Detail

Sections
Recommended

AI思维导图

/